These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. Jacobs MH; Senior RM; Kessler G JAMA; 1976 May; 235(18):1983-6. PubMed ID: 946508 [TBL] [Abstract][Full Text] [Related]
18. Intersubject variability in plasma theophylline levels after oral and intravenous administration in Jordanian patients with chronic obstructive pulmonary disease. Samara N; Sliman N; Sai'd S; Awidi A; Al-Turk W; Othman S; Khalaf R; Shaheen O Ther Drug Monit; 1988; 10(2):144-6. PubMed ID: 3381229 [TBL] [Abstract][Full Text] [Related]
19. Recommended standard theophylline doses are inadequate in chronic obstructive pulmonary disease. Savage J; Wiseman IC S Afr Med J; 1987 Apr; 71(8):508-9. PubMed ID: 3563816 [TBL] [Abstract][Full Text] [Related]
20. Clinical use of controlled-release theophylline in chronic airways obstruction. Dal Negro R; Turco P; Pomari C; Cordaro CI J Int Med Res; 1987; 15(6):391-6. PubMed ID: 3436486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]